skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 4,662  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Animals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ten Strategies of Interferon Evasion by Viruses
Material Type:
Article
Add to My Research

Ten Strategies of Interferon Evasion by Viruses

Cell host & microbe, 2017-08, Vol.22 (2), p.176-184 [Peer Reviewed Journal]

2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;2017 Elsevier Inc. 2017 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2017.07.012 ;PMID: 28799903

Full text available

2
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Material Type:
Article
Add to My Research

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Nature Communications, 2020-01, Vol.11 (1), p.222-14, Article 222 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by/4.0 ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-13940-6 ;PMID: 31924756

Digital Resources/Online E-Resources

3
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Material Type:
Article
Add to My Research

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

mBio, 2018-03, Vol.9 (2) [Peer Reviewed Journal]

Copyright © 2018 Agostini et al. ;Copyright © 2018 Agostini et al. 2018 Agostini et al. ;ISSN: 2161-2129 ;EISSN: 2150-7511 ;DOI: 10.1128/mbio.00221-18 ;PMID: 29511076

Full text available

4
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Material Type:
Article
Add to My Research

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Proceedings of the National Academy of Sciences - PNAS, 2020-03, Vol.117 (12), p.6771-6776 [Peer Reviewed Journal]

Copyright National Academy of Sciences Mar 24, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1922083117 ;PMID: 32054787

Full text available

5
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Material Type:
Article
Add to My Research

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

The Journal of biological chemistry, 2020-05, Vol.295 (20), p.6785-6797 [Peer Reviewed Journal]

2020 © 2020 Gordon et al. ;2020 Gordon et al. ;2020 Gordon et al. 2020 Gordon et al. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.RA120.013679 ;PMID: 32284326

Full text available

6
Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design
Material Type:
Article
Add to My Research

Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design

Nature reviews. Molecular cell biology, 2022-01, Vol.23 (1), p.21-39 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1471-0072 ;EISSN: 1471-0080 ;DOI: 10.1038/s41580-021-00432-z ;PMID: 34824452

Full text available

7
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Material Type:
Article
Add to My Research

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

Science, 2020-04, Vol.368 (6489) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abb3405

Digital Resources/Online E-Resources

8
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells
Material Type:
Article
Add to My Research

The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells

Journal of virology, 2020-12, Vol.95 (1) [Peer Reviewed Journal]

Copyright © 2020 American Society for Microbiology. ;Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.01648-20 ;PMID: 33055254

Full text available

9
α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
Material Type:
Article
Add to My Research

α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment

Journal of Medicinal Chemistry, 2020-05, Vol.63 (9) [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.acs.org/content/acs/en/terms.html ;DOI: 10.1021/acs.jmedchem.9b01828

Digital Resources/Online E-Resources

10
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Material Type:
Article
Add to My Research

X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease

Science, 2021-05, Vol.372 (6542) [Peer Reviewed Journal]

2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abf7945

Digital Resources/Online E-Resources

11
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Material Type:
Article
Add to My Research

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Science Translational Medicine, 2020-04, Vol.12 (541) [Peer Reviewed Journal]

2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/scitranslmed.abb5883

Digital Resources/Online E-Resources

12
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Material Type:
Article
Add to My Research

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

The Journal of biological chemistry, 2020-04, Vol.295 (15), p.4773-4779 [Peer Reviewed Journal]

2020 © 2020 Gordon et al. ;2020 Gordon et al. ;2020 Gordon et al. 2020 Gordon et al. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.AC120.013056 ;PMID: 32094225

Full text available

13
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Material Type:
Article
Add to My Research

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Cell research, 2020-08, Vol.30 (8), p.678-692 [Peer Reviewed Journal]

Center for Excellence in Molecular Cell Science, CAS 2020. ;Center for Excellence in Molecular Cell Science, CAS 2020 ;ISSN: 1001-0602 ;EISSN: 1748-7838 ;DOI: 10.1038/s41422-020-0356-z ;PMID: 32541865

Full text available

14
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
Material Type:
Article
Add to My Research

β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells

The Journal of infectious diseases, 2021-08, Vol.224 (3), p.415-419 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiab247 ;PMID: 33961695

Full text available

15
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
Material Type:
Article
Add to My Research

Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo

Journal of virology, 2020-10, Vol.94 (21) [Peer Reviewed Journal]

Copyright © 2020 American Society for Microbiology. ;Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.01218-20 ;PMID: 32817221

Full text available

16
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
Material Type:
Article
Add to My Research

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

Nature (London), 2021-06, Vol.594 (7861), p.88-93 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jun 3, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03491-6 ;PMID: 33827113

Full text available

17
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
Material Type:
Article
Add to My Research

Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients

Acta pharmacologica Sinica, 2020-09, Vol.41 (9), p.1167-1177 [Peer Reviewed Journal]

CPS and SIMM 2020. ;CPS and SIMM 2020 ;ISSN: 1671-4083 ;EISSN: 1745-7254 ;DOI: 10.1038/s41401-020-0483-6 ;PMID: 32737471

Full text available

18
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Material Type:
Article
Add to My Research

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

Nature communications, 2020-08, Vol.11 (1), p.4282-8, Article 4282 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-18096-2 ;PMID: 32855413

Full text available

19
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses
Material Type:
Article
Add to My Research

Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses

Journal of virology, 2016-11, Vol.90 (21), p.9683-9692 [Peer Reviewed Journal]

Copyright © 2016, American Society for Microbiology. All Rights Reserved. ;Attribution - NonCommercial - NoDerivatives ;Copyright © 2016, American Society for Microbiology. All Rights Reserved. 2016 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.01347-16 ;PMID: 27535047

Full text available

20
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Material Type:
Article
Add to My Research

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis

Nature structural & molecular biology, 2021-09, Vol.28 (9), p.740-746 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1545-9993 ;EISSN: 1545-9985 ;DOI: 10.1038/s41594-021-00651-0 ;PMID: 34381216

Full text available

Results 1 - 20 of 4,662  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (4,482)

Refine My Results

Creation Date 

From To
  1. Before 1976  (385)
  2. 1976 To 1987  (657)
  3. 1988 To 1999  (957)
  4. 2000 To 2012  (1,257)
  5. After 2012  (1,414)
  6. More options open sub menu

Resource Type 

  1. Articles  (4,661)
  2. Web Resources  (1)
  3. More options open sub menu

Language 

  1. English  (4,622)
  2. Japanese  (889)
  3. French  (21)
  4. German  (14)
  5. Portuguese  (14)
  6. Russian  (10)
  7. Chinese  (5)
  8. Spanish  (4)
  9. Norwegian  (1)
  10. Korean  (1)
  11. Dutch  (1)
  12. More options open sub menu

Searching Remote Databases, Please Wait